The implementation of per-se limits for driving under the influence of benzodiazepines and related drugs: No increased risk for arrest during therapeutic use in Norway

References

• Berghaus G, Sticht G, Grellner W, Lenz D, Naumann T, Wiesenmüller S. 2011. Meta-analysis of empirical studies concerning the effects of medicines and illegal drugs including pharmacokinetics on safe driving. DRUID Deliverable 1.1.2b. Würzburg, Germany: University of Würzburg. https://www.bast.de/Druid/EN/deliverales-list/downloads/Deliverable_1_1_2_B.html.
   Google Scholar
• Blomberg RD, Peck RC, Moskowitz H, Burns M, Fiorentino D, 2009. The Long Beach/Fort Lauderdale relative risk study. J Safety Res. 40(4):285–92. doi:10.1016/j.jsr.2009.07.002
   PubMed Web of Science ®Google Scholar
• Bogstrand ST, Middelkoop G, Christophersen AS, 2011. Trends in amphetamine and benzodiazepine use among drivers arrested for drug impaired driving in Norway 2000–2009. Nor Epidemiol. 21(1):61–6. doi:10.5324/nje.v21i1.1427
   PubMed Web of Science ®Google Scholar
• Borkenstein RF, Crowther RF, Shumate RF, Ziel WB, Zylman R, 1974. The role of the drinking driver in traffic accidents (the Grand Rapids study). Blutalkohol. 11(Suppl. 1):1–131.
   Google Scholar
• Bramness JG, Skurtveit S, Mørland J, 2003. Testing for benzodiazepine inebriation–relationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers. Eur J Clin Pharmacol. 59(8–9):593–601. doi:10.1007/s00228-003-0677-0
   PubMed Web of Science ®Google Scholar
• Christophersen AS, Mørland J, Stewart K, Gjerde H, 2016. International trends in alcohol and drug use among motor vehicle drivers. Forensic Sci Rev. 28(1):37–66.
   PubMedGoogle Scholar
• Christophersen ARS, Mørland JR, 2008. Frequent detection of benzodiazepines in drugged drivers in Norway. Traffic Inj Prev. 9(2):98–104. doi:10.1080/15389580701869190
   PubMed Web of Science ®Google Scholar
• Dassanayake T, Michie P, Carter G, Jones A, 2011. Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence. Drug Saf. 34(2):125–56. doi:10.2165/11539050-000000000-00000
   PubMed Web of Science ®Google Scholar
• Dollery C. 2011. Therapeutic drugs. 2nd ed. London (UK): Churchill Livingstone.
   Google Scholar
• Gjerde H, Christophersen AS, Normann PT, Assum T, Øiestad EL, Mørland J, 2013. Norwegian roadside survey of alcohol and drug use by drivers (2008–2009). Traffic Inj Prev. 14(5):443–52. doi:10.1080/15389588.2012.728016
   PubMed Web of Science ®Google Scholar
• Jones AW, Mørland JG, Liu RH, 2019. Driving under the influence of psychoactive substances - A historical review. Forensic Sci Rev. 31(2):103–40.
   PubMedGoogle Scholar
• Kristoffersen L, Strand DH, Liane VH, Vindenes V, Tvete IF, Aldrin M, 2016. Determination of safety margins for whole blood concentrations of alcohol and nineteen drugs in driving under the influence cases. Forensic Sci Int. 259:119–26. doi:10.1016/j.forsciint.2015.12.009
   PubMed Web of Science ®Google Scholar
• Longo MC, Lokan RJ, White JM, 2001. The relationship between blood benzodiazepine concentration and vehicle crash culpability. J Traffic Med. 29:36–43.
   Google Scholar
• Moffat AC, Osselton MD, Widdop B. 2011. Clarke’s analysis of drugs and poisons. 4th ed. London (UK): Pharmaceutical Press.
   Google Scholar
• Mørland J, 2000. Driving under the influence of non-alcohol drugs. Forensic Sci Rev. 12(1–2):79–105.
   PubMedGoogle Scholar
• Norwegian Directorate of Health. 2011. Retningslinjer for fylkesmennene ved behandling av førerkortsaker. IS-1348. Oslo (Norway): Norwegian Directorate of Health.
   Google Scholar
• Rowland M, Tozer TN. 2010. Clinical pharmacokinetics and pharmacodynamics: concepts and applications. Philadelphia (PA): Lippincott Williams & Wilkins.
   Google Scholar
• Valen A, Bogstrand ST, Vindenes V, Gjerde H, 2017. Toxicological findings in suspected drug-impaired drivers in Norway - Trends during 1990–2015. Forensic Sci Int. 280:15–24. doi:10.1016/j.forsciint.2017.09.010
   PubMed Web of Science ®Google Scholar
• Verstraete A, Knoche A, Jantos R, Skopp G, Gjerde H, Vindenes V, Mørland J, Langel K, Lillsunde P. 2011. Per se limits - methods of defining cut-off values for zero tolerance. DRUID Deliverable D1.4.2. Ghent (Belgium): Ghent University. https://biblio.ugent.be/publication/1988464/file/1988490.pdf.
   Google Scholar
• Vindenes V, Boix F, Koksaeter P, Strand MC, Bachs L, Mørland J, Gjerde H, 2014. Drugged driving arrests in Norway before and after the implementation of per se law. Forensic Sci Int. 245:171–7. doi:10.1016/j.forsciint.2014.10.038
   PubMed Web of Science ®Google Scholar
• Vindenes V, Jordbru D, Knapskog AB, Kvan E, Mathisrud G, Slørdal L, Mørland J, 2012. Impairment based legislative limits for driving under the influence of non-alcohol drugs in Norway. Forensic Sci Int. 219(1–3):1–11. doi:10.1016/j.forsciint.2011.11.004
   PubMed Web of Science ®Google Scholar
• Vindenes V, Aamo T, Innerdal C, Mathisrud G, Mørland J, Riedel B, Slørdal L, Strand MC. 2015. Revidering av “forskrift om faste grenser for påvirkning av andre berusende eller bedøvende middel enn alkohol m.m.” – Vurdering av eksisterende faste grenser og forslag til faste grenser for flere stoffer [Revision of “Regulations on fixed limits for impairment by other intoxicating or anaesthetic/sedative substances than alcohol etc.” – assessment of existing fixed limits and proposed fixed limits for additional substances]. Oslo (Norway): Ministry of Transport and Communications. https://www.regjeringen.no/contentassets/21dac5b787734d7b80f45d30c88e8632/hbrev2304rapport.pdf.
   Google Scholar
• WHO. 2014. Global status report on alcohol and health. Geneva (Switzerland): World Health Organization. http://www.who.int/substance_abuse/publications/global_alcohol_report/msb_gsr_2014_1.pdf.
   Google Scholar